|Mr. Mark Anthony Nicholas Zekulin||CEO & Director||N/A||N/A||N/A|
|Mr. Rade Kovacevic||Acting Pres||N/A||N/A||N/A|
|Mr. Phillip S. Shaer||Chief Legal Officer & VP of HR||N/A||N/A||N/A|
|Mr. Christopher James Schnarr||Sr. VP||N/A||N/A||1967|
|Mr. Timothy Rob Saunders||Strategic Advisor||N/A||N/A||N/A|
Canopy Growth Corporation, together with its subsidiaries, engages in engages in production, distribution, and sale of cannabis in Canada. It operates through two segments, Cannabis Operations and Canopy Rivers. The company's products include dried flowers, oils and concentrates, softgel capsules, and hemps. It offers its products under the Tweed, Spectrum, DNA Genetics, CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Maitri brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; partnership with Parent Action on Drugs; and a collaboration with Cure Pharmaceutical Holding Corp. for the development of low-dose cannabidiol oral thin films. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Canopy Growth Corporation’s ISS Governance QualityScore as of October 4, 2019 is 9. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 6; Compensation: 9.